Liminal BioSciences
Biotechnology ResearchQuebec, Canada11-50 Employees
Liminal BioSciences is a data-driven development-stage biopharmaceutical company focused on discovering small molecule therapeutics that modulate G protein-coupled receptor pathways. Through its wholly owned subsidiary, Caledon Bioscience Inc., the company aims to develop first- or best-in-class treatments for metabolic, inflammatory, and fibrotic diseases, leveraging its expertise in drug discovery and medicinal chemistry and its understanding of GPCR biology. The organization positions itself within the biotechnology research industry as a partner capable of translating GPCR biology into novel therapeutic candidates, with a focus on addressing significant unmet medical needs. Based in Belleville, Ontario with talent hubs in Quebec and the United Kingdom, Liminal BioSciences operates in a research and development capacity within Canada and abroad. The business maintains a corporate footprint in Laval, Quebec, and lists its activities and corporate presence across multiple locations to support its development programs. A recent development noted in public sources indicates a corporate event involving an acquisition by Structured Alpha, reflecting ongoing changes in its corporate trajectory.
1-888-653-2347 
support@leadiq.com 
